Riabni™ (rituximab-arrx)
for Arthritis Rheumatoid

Riabni (rituximab-arrx) is a monoclonal antibody that targets B cells to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and pemphigus vulgaris. By destroying B cells, it helps manage cancer, autoimmune diseases, and immune-related conditions.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Arthritis Rheumatoid